GLEAN Membranoproliferative Glomerulonephritis (MPGN) Project

C3 Glomerulopathy (C3G) and Immune Complex-associated Membranoproliferative Glomerulonephritis (IC-MPGN) are kidney diseases with different causes. C3G results from problems with the alternative complement pathway, while IC-MPGN is linked to the classical complement pathway due to immune complex formation. These conditions have often been grouped as types of membranoproliferative glomerulonephritis (MPGN) based on their appearance under a microscope, leading to confusion about their biology and treatment options.

Certain groups of patients respond better to immunosuppressive and complement-targeted therapies, and their specific characteristics can help predict treatment outcomes. Most existing studies on C3G and IC-MPGN focus on adults and are small in scale.

In this study, the research team aims to identify and characterize children with C3G and IC-MPGN in the PEDSnet database using data science and chart reviews. The long-term goal is to conduct a large study to understand the natural history of these diseases in children, compare clinical outcomes, and identify predictors of how patients respond to treatment.

Clinical Outcomes by Language of Care in Pediatric Oncology

Although language disparities in outcomes are well documented in general pediatrics and adult oncology, little is known in pediatric oncology. Patient or family language is not included in many multi- institutional databases and patient registries, limiting studies of language-based inequities…

Extreme weather impacts on children’s acute and chronic health outcomes; a multisite study with evaluation of vulnerabilities

The “Extreme Weather and Pediatric Health Outcomes” study investigates the impact of climate change-related extreme weather events, such as extreme heat and heavy rainfall, on children’s health across the United States. This innovative research aims to address critical knowledge gaps…

Characterization of Babies Born with Hemolytic Disease of the Fetus/Newborn (HDFN)

Hemolytic disease of the fetus and newborn (HDFN) otherwise known as erythroblastosis fetalis, is a disease in which fetal and neonatal erythrocytes are destroyed by maternal IgG alloantibodies. Before the first RhD immunoprophylaxis was introduced as a treatment in 1968,…

Scroll to Top